360° SearchNetwork Hot Spots Trends Time Series

ACE Inhibitors

Type: Keyphrase

Name: ACE Inhibitors

First reported 10 hours ago - Updated 10 hours ago - 1 reports

Common Drug Can Limit Radiation Damage to Cancer Patient’s Heart, Lungs

— Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers ... [Published Diagnostic & Invasive Cardiology - 10 hours ago]

Entities: Angiotensin Converting Enzyme, captopril, Radiation, Irradiation, Radiation Therapy

First reported 17 hours ago - Updated 17 hours ago - 1 reports

Study identifies superior hypertension treatment, efficacy between sexes

(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to non-diuretic-based antihypertensive therapies like ... [Published Medical Xpress - 17 hours ago]

Entities: Diuretic, Hypertension, Cardiovascular Disease

First reported May 21 2013 - Updated May 21 2013 - 1 reports

American Heart Association

Memorial Hospital Receives Award For Heart Attack Care

Memorial Hospital has received the American Heart Association’s Mission: Lifeline® Silver Receiving Quality Achievement Award. The award recognizes Memorial’s commitment and success in implementing an exceptional standard of care for heart attack pat ... [Published Chattanoogan - May 21 2013]

Entities: Heart Attack, Patient, American Heart Association, Artery

First reported May 20 2013 - Updated May 21 2013 - 1 reports

European Medicines Agency Starts Review of Combined Use Of Drugs That Block The Renin-Angiotensin System

The European Medicines Agency said last week that it was initiating a review of the combined use of agents that block the renin-angiotensin system (RAS). The three classes of RAS-blocking drugs (ACE ACEThe EMA said that the review was being performed ... [Published Forbes.com - May 20 2013]

Entities: European Medicines Agency, Hyperkalemia, hypotension

First reported May 20 2013 - Updated May 20 2013 - 1 reports

FDA Food & Drug Administration

Side effects of medicine can make you feel sicker

A few years ago, I developed a painful infection. My doctor prescribed an antibiotic and a second drug to alleviate the agonizing, burning sensation. Despite the medicine, my misery increased. After a desperate call to my doctor, I deduced that my worsening ... [Published Charlotte Observer - May 20 2013]

Entities: Drugs, Patient, FDA Food & Drug Administration, Angiotensin Converting Enzyme

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Cardiology pocket

The app by Brm Bruckmeier Publishing aims to provide todays busy clinicians with an overview of the current approaches to diagnosing and treating heart and cardiovascular disease, in a concise and highly accessible format. This comprehensive guide covers ... [Published ZDNet - May 20 2013]

Entities: Cardiology, thromboembolism, Hypertension, guidelines

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Asparagus Reduces High Blood Pressure – New Discovery

http://www.aboutbloodpressure.ca/asparagus-reduces-high-blood-pressure-new-discovery/ New research concludes that dietary intake of asparagus lowers blood pressure. The researchers were able to isolate an active compound found in asparagus that was found ... [Published Now Public - May 18 2013]

Entities: Asparagus, Hypertension, ACE Inhibitors

First reported May 18 2013 - Updated May 18 2013 - 1 reports

To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective

Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW: Efficacy and safety of benazepril for advanced chronic renal insufficiency N Engl J Med 2006;354:131-140.Dutch End-Stage Renal Disease Registry (Registratie ... [Published Sexual Development - May 18 2013]

Entities: Angiotensin Converting Enzyme, Kidney, ACE Inhibitors, Hypertension, Benazepril

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Heart failure performance measures: Eligibility and implementation in the community - Corrected Proof

Background: The goal of heart failure (HF) performance measures is to improve quality of care by assessing the implementation of guidelines in eligible patients. Little is known about the proportion of eligible patients and how performance measures are ... [Published American Heart Journal - May 09 2013]

Entities: congestive heart failure, ACE Inhibitors, Patient

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

ITALIAN CHEESE LOWERS YOUR BLOOD PRESSURE!

http://www.aboutbloodpressure.ca/italian-cheese-lowers-your-blood-pressure/ May 4, 2012 (London, United Kingdom) — Integrating a particular type of Italian cheese, Grana Padano, into the usual diet of mildly hypertensive patients not taking any ACE inhibitors ... [Published Now Public - Apr 30 2013]

Entities: ACE Inhibitors, Grana, Patient

First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

ACE inhibitors can limit damage to heart, lungs from radiotherapy

Administration of an angiotensin-converting enzyme (ACE) inhibitor used in (more) ... [Published AuntMinnieEurope - Apr 24 2013]

Entities: ACE Inhibitors, Radiation Therapy, Angiotensin Converting Enzyme

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Study: Cardiovascular Drug Captopril May Limit Radiation Damage to Lungs and Heart in Cancer Patients

Unavoidable damage caused to the heart and lungs by radiotherapy of tumors in the chest may be limited by the administration of an angiotensin-converting enzyme (ACE) inhibitor, a drug commonly used in the treatment of cardiovascular disease, according ... [Published PT Community - Apr 22 2013]

Entities: captopril, Radiation, Irradiation, Angiotensin Converting Enzyme, ACE Inhibitors

Quotes

President of ESTRO, Professor Vincenzo Valentini, a radiation oncologist at the Policlinico Universitario A Gemelli, Rome, Italy, said: "This study underlines the importance of translational research. The understanding of anti-cancer mechanisms, as well as of protective opportunities discovered in the experimental environment, is of upmost importance in the era of personalized medicine. This research provides further evidence of the importance of testing experimental theories in the clinical environment to the ultimate benefit of patients."

Common Drug Can Limit Radiation Damage to Cancer Patient’s Heart, Lungs [Published Diagnostic & Invasive Cardiology - 10 hours ago]

"When choosing first-step drugs, this evidence clearly suggests both men and women can benefit by starting with a diuretic" she said

Study identifies superior hypertension treatment, efficacy between sexes [Published Medical Xpress - 17 hours ago]

Messerli responded that this "means you still may use dual RAS provided you âclosely monitorâ the above. To my way of thinking this is not acceptable. Since we have no outcome data showing benefit for dual RAS blockade, this is not simply a question of closely monitoring."

European Medicines Agency Starts Review of Combined Use Of Drugs That Block The Renin-Angiotensin ... [Published Forbes.com - May 20 2013]

Continued Dr. Blobel: "With the just announced licensing agreement with Zensun (Shanghai) Science & Technology for Neucardin™, a novel, first-in-class treatment for chronic heart failure, we are fulfilling a major corporate goal to expand our product portfolio with a high quality, differentiated therapeutic with significant commercial potential to help drive our long-term growth. We believe that Neucardin has near-term commercial potential and can contribute to our long-term growth. We look forward to working with our partner Zensun to advance this promising product through the regulatory and commercial process."

SciClone Reports Anticipated Financial Results for the First Quarter 2013 [Published FinanzNachrichten.de - May 16 2013]

More Content

sort by: Date \| Relevance
Common Drug Can Limit Radiation Damage to Cance... [Published Diagnostic & Invasive Cardiology - 10 hours ago]
Study identifies superior hypertension treatmen... [Published Medical Xpress - 17 hours ago]
Recent Study: Aanjaneya Lifecare Limited (AANJA... [Published Live-PR.com - 19 hours ago]
Memorial Hospital Receives Award For Heart Atta... [Published Chattanoogan - May 21 2013]
SciClone Pharmaceuticals, Inc. (SCLN) - Pharmac... [Published TransWorldNews - May 21 2013]
European Medicines Agency Starts Review of Comb... [Published Forbes.com - May 20 2013]
Side effects of medicine can make you feel sicker [Published Charlotte Observer - May 20 2013]
Merlo: CVS aims to be part of health care solution [Published Chain Drug Review - May 20 2013]
Cardiology pocket [Published ZDNet - May 20 2013]
Invisible enemy [Published thestar.com.my - May 19 2013]
Asparagus Reduces High Blood Pressure – New Dis... [Published Now Public - May 18 2013]
To Treat or Not to Treat? Cost-Effectiveness of... [Published Sexual Development - May 18 2013]
SciClone Reports Anticipated Financial Results ... [Published FinanzNachrichten.de - May 16 2013]
SciClone and Zensun Enter Into a Licensing Agre... [Published FinanzNachrichten.de - May 16 2013]
Menarini provides Pinoys with innovative, affor... [Published Philippine Star - May 15 2013]
Bristol-Myers Targets Heart-Failure Drugs in R&... [Published Bloomberg - May 15 2013]
Arbor Pharmaceuticals Announces FDA Approval of... [Published Zecco - May 13 2013]
Side effects of prescription drugs can be repor... [Published Washington Post - May 13 2013]
Pet Ownership Linked With Better Heart Health [Published Huffington Post - May 13 2013]
Cumberland Pharmaceuticals Licenses Caldolor$ (... [Published AndhraNews.net - May 13 2013]
News: Studying Adherence [Published Pharmaceutical & Medical Packaging News - May 11 2013]
Celladon Corporation and SIRO Clinpharm Announc... [Published AndhraNews.net - May 11 2013]
SciClone Pharmaceuticals, Inc. (SCLN) - Financi... [Published TransWorldNews - May 10 2013]
Celladon Corp and SIRO Clinpharm to present ana... [Published Express Pharma - May 10 2013]
Upcoming Catalysts Could Push ChemoCentryx To D... [Published Seeking Alpha - May 10 2013]
Heart failure performance measures: Eligibility... [Published American Heart Journal - May 09 2013]
Celladon Corporation and SIRO Clinpharm Announc... [Published Yahoo! Finance - May 08 2013]
Celladon Corporation and SIRO Clinpharm Announc... [Published Reuters - May 08 2013]
Celladon Corporation and SIRO Clinpharm Announc... [Published PR Newswire - May 08 2013]
Celladon Corporation and SIRO Clinpharm Announc... [Published GBS Venture Partners - May 08 2013]

Blogs

sort by: Date \| Relevance
Egg White Protein May Help Lower High Blood Pre... [Published Scientific Blogging - Medicine - Apr 11 2013] A component of egg whites, already a popular whole egg substitute among cholesterol-conscious consumers concerned, may have another beneficial effect - reducing blood pressure, according to a study presented earlier this week at the American Chemical ...
Why Patient Engagement Really Does Matter and W... [Published The Health Care Blog - Mar 12 2013] By Rob Lamberts, MD “Patient engagement.” What is “Patient Engagement?” It sounds like a season of “The Bachelor” where a doctor dates hot patients. It wouldn’t surprise me if it was. After all, patient engagement is hot; it’s the new buzz phrase ...
Getting Engaged [Published Musings of a Distractible Mind - Mar 12 2013] “Patient engagement.” What is “Patient Engagement?” It sounds like a season of “The Bachelor” where a doctor dates hot patients. It wouldn’t surprise me if it was. After all, patient engagement is hot; it’s the new buzz phrase for health wonks. ...
Pharmalot… Pharmalittle… Good Morning [Published Pharmalot - Feb 06 2013] And so, the middle of the week has arrived. However, we are breaking from our usual routine so that we can speak at the Healthcare Supply Chain Association forum later today ( see this ). As a result, a colleague may be enlisted to fill in for us over ...
MKSAP: 62-year-old man is evaluated during a ro... [Published KevinMD.com - Dec 15 2012] Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians . A 62-year-old man is evaluated during a routine examination. Medical history is significant for a myocardial infarction 3 years ago, dyslipidemia, ...

Press Releases

sort by: Date \| Relevance
Celladon Corporation and SIRO Clinpharm Announc... [Published PR Newswire - May 08 2013]